Zhan; Weiqiang

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zhan; Weiqiang.The latest application filed is for "compositions and methods for treating reperfusion injury or hemorrhage after recanalization therapy".

Company Profile

0.4.9

Zhan; Weiqiang - Alpharetta GA
Zhan; Weiqiang - Shanghai CN
Zhan; Weiqiang - Decatur GA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions And Methods For Treating Reperfusion Injury Or Hemorrhage After Recanalization Therapy App 20210283080 - Gwag; Byoung Joo ; et al.	2021-09-16
Pyrazole Compounds App 20170334885 - Ho; Koc Kan ; et al.	2017-11-23
Pyrazole compounds Grant 9,822,101 - Ho , et al. November 21, 2	2017-11-21
CXCR4 Antagonists for the Treatment of Medical Disorders App 20160002174 - Shim; Hyunsuk ; et al.	2016-01-07
Cxcr4 Antagonists For The Treatment Of Medical Disorders App 20140039187 - Shim; Hyunsuk ; et al.	2014-02-06
CXCR4 antagonists for the treatment of medical disorders Grant 8,114,884 - Shim , et al. February 14, 2	2012-02-14
CXCR4 antagonists including diazine and triazine structures for the treatment of medical disorders Grant 8,080,659 - Liotta , et al. December 20, 2	2011-12-20
CXCR4 antagonists for the treatment of HIV infection Grant 8,008,312 - Shim , et al. August 30, 2	2011-08-30
CXCR4 Antagonists Including Diazine And Triazine Structures For The Treatment Of Medical Disorders App 20090099194 - Liotta; Dennis C. ; et al.	2009-04-16
CXCR4 Antagonists Including Heteroatoms for the Treatment of Medical Disorders App 20080227799 - Liotta; Dennis C. ; et al.	2008-09-18
CXCR4 antagonists for the treatment of medical disorders App 20070054930 - Shim; Hyunsuk ; et al.	2007-03-08
CXCR4 antagonists for the treatment of HIV infection App 20060264451 - Shim; Hyunsuk ; et al.	2006-11-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.